1. |
Occhi G, Barollo S, Regazzo D, et al. A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC. Oncotarget, 2015, 6(31):32104-32114.
|
2. |
Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA, 2006, 295(18):2164-2167.
|
3. |
Ramakrishna S, Kim IM, Petrovic V, et al. Myocardium defects and ventricular hypoplasia in mice homozygous null for the Forkhead Box M1 transcription factor. Dev Dyn, 2007, 236(4):1000-1013.
|
4. |
Brezillon N, Lambert-Blot M, Morosan S, et al. Transplanted hepato-cytes over-expressing FoxM1B efficiently repopulate chronically injured mouse liver independent of donor age. Mol Ther, 2007, 15(9):1710-1715.
|
5. |
Korver W, Roose J, Heinen K, et al. The human Trident/HFH-11/ FKHL16 gene:structure, localization, and promoter characterization. Genomics, 1997, 46(3):435-442.
|
6. |
Yau C, Meyer L, Benz S, et al. FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index. Breast Cancer Res Treat, 2015, 154(1):23-32.
|
7. |
王一茹, 姚斌伟, 张艳, 等. FoxM1 shRNA慢病毒载体构建及感染人前列腺癌细胞的稳定细胞株筛选. 南方医科大学学报, 2015, 35(9):1227-1233.
|
8. |
Zhang HG, Xu XW, Shi XP, et al. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer. Clin Transl Oncol, 2015 Sep 14.
|
9. |
袁浩, 陈进宏, 闵志均, 等. FoxM1基因表达与甲状腺乳头状癌TPC-1细胞活性及侵袭性关系的研究. 中华内分泌外科杂志, 2014, 7(4):265-268.
|
10. |
Guan H, Ji M, Bao R, et al. Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab, 2009, 94(5):1612-1617.
|
11. |
王玉龙, 王久存, 李端树, 等. 甲状腺乳头状癌的基因重排分析. 中华耳鼻咽喉头颈外科杂志, 2007, 42(12):929-933.
|
12. |
于波洋, 杨盼, 马步云, 等. 甲状腺乳头状癌BRAF基因表达及侵袭性研究. 中国普外基础与临床杂志, 2015, 22(7):795-798.
|
13. |
Zou M, Baitei EY, Alzahrani AS, et al. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma. Thyroid, 2014, 24(8):1256-1266.
|
14. |
Matsumoto H, Sakamoto A, Fujiwara M, et al. Cyclic AMP-mediated growth suppression and MAPK phosphorylation in thyroid papillary carcinoma cells. Mol Med Rep, 2011, 1(2):245-249.
|
15. |
贾永胜. EGFR介导的MAPK再活化在BRAFV600E基因突变的甲状腺乳头状癌中的作用研究. 第六届全国甲状腺肿瘤学术大会论文集. 天津:中国抗癌协会甲状腺肿瘤专业委员会, 中华医学会肿瘤分会头颈学组, 2014:23-25.
|
16. |
Nan XL, Tamgüney TM, Collisson EA, et al. Ras-GTP dimers activate the mitogen-activated protein kinase (MAPK) pathway. Proc Natl Acad Sci USA, 2015, 112(26):7996-8001.
|
17. |
Liu W, Ning R, Chen RN, et al. Aspafilioside B induces G2/M cell cycle arrest and apoptosis by up-regulating H-Ras and N-Ras via ERK and p38MAPK signaling pathways in human hepatoma HepG2 cells. Mol Carcinog, 2015 Feb 14. doi:10.1002/mc.22293.
|
18. |
Nabti I, Marangos P, Bormann J, et al. Dual-mode regulation of the APC/C by CDK1 and MAPK controls meiosis Ⅰ progression and fidelity. J Cell Biol, 2014, 204(6):891-900.
|
19. |
Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer, 2007, 7(11):847-859.
|
20. |
Ma RY, Tong TH, Cheung AM, et al. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J Cell Sci, 2005, 118(Pt 4):795-806.
|
21. |
Laoukili J, Alvarez M, Meijer LA, et al. Activation of FoxM1 during G2 requires cyclin A/Cdk-dependent relief of autorepression by the FoxM1 N-terminal domain. Mol Cell Biol, 2008, 28(9):3076-3087.
|
22. |
Alvarez-Fernández M, Halim VA, Krenning L, et al. Recovery from a DNA-damage-induced G2 arrest requires Cdk-dependent activation of FoxM1. EMBO Rep, 2010, 11(6):452-458.
|
23. |
Ahmed M, Uddin S, Hussain AR, et al. FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma. J Clin Endocrinol Metab, 2012, 97(1):E1-E13.
|
24. |
Bellelli R, Castellone MD, Garcia-Rostan G, et al. FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. Endocr Relat Cancer, 2012, 19(5):695-710.
|
25. |
Kopanja D, Pandey A, Kiefer M, et al. Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features. J Hepatol, 2015, 63(2):429-436.
|